➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Moodys
Baxter
Johnson and Johnson
Dow

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Asparaginase - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for asparaginase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Hunan Cancer HospitalPhase 2
Fundação Rui Osório de CastroPhase 3
The Swedish Research CouncilPhase 3

See all asparaginase clinical trials

Recent Litigation for asparaginase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Ravgen, Inc. v. Natera, Inc.2020-06-01
Ravgen, Inc. v. PerkinElmer Inc.2020-06-01
Genentech, Inc. v. Pfizer Inc.2019-04-05

See all asparaginase litigation

PTAB Litigation
PetitionerDate
2017-11-17
2016-09-09
2013-01-28

See all asparaginase litigation

Patent Text Search: US Patents for asparaginase

These patents were identified by searching patent claims

Supplementary Protection Certificates for asparaginase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2007 00027 Denmark   Start Trial PRODUCT NAME: PERFLUTREN-HOLDIGE LIPIDMIKROSAERER
C018/2007 Ireland   Start Trial SPC018/2007: 20071012, EXPIRES: 20190519
2007901505158 Italy   Start Trial PRODUCT NAME: MICROSFERE LIPIDICHE CONTENENTI PERFLUTRENO(LUMINITY); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/06/361/001, 20060920
27/2007 Austria   Start Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL
/2007 Austria   Start Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL; REGISTRATION NO/DATE: EU/1/06/361/001 20060920
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
AstraZeneca
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.